LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN CALCIUM) — FDA Approval ANDA206263 (HIKMA)
LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN CALCIUM) — FDA Approval ANDA206263 (HIKMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LEVOLEUCOVORIN CALCIUM; Active ingredients: LEVOLEUCOVORIN CALCIUM; Application number: ANDA206263.
| Brand name | LEVOLEUCOVORIN CALCIUM |
|---|---|
| Active ingredients | LEVOLEUCOVORIN CALCIUM |
| Application number | ANDA206263 |
| Sponsor | HIKMA |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20160616 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →